Publications

Activity of Oritavancin Tested against Uncommonly Isolated Gram-positive Pathogens Responsible for Documented Infections in Hospitals Worldwide, Lead author: Mendes RE, presented at 53rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 10 -13, 2013, Denver, CO

View publication